{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04089072",
            "orgStudyIdInfo": {
                "id": "IRB 19-549"
            },
            "organization": {
                "fullName": "Carilion Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Methylene Blue as a Third-line Vasopressor in Septic Shock",
            "officialTitle": "Methylene Blue as a Third-line Vasopressor in Septic Shock to Maintain Hemodynamics",
            "therapeuticArea": [
                "Other"
            ],
            "study": "methylene-blue-as-a-third-line-vasopressor-in-septic-shock"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-12-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-10-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-11-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-08-23",
            "studyFirstSubmitQcDate": "2019-09-12",
            "studyFirstPostDateStruct": {
                "date": "2019-09-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-07-22",
            "lastUpdatePostDateStruct": {
                "date": "2022-07-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Frank H Biscardi",
                "investigatorTitle": "MD",
                "investigatorAffiliation": "Carilion Clinic"
            },
            "leadSponsor": {
                "name": "Carilion Clinic",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Provepharm Life Solutions",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "A randomized, prospective study comparing ProvayBlue\u00ae to standard care with multiple sympathomimetic vasopressors.",
            "detailedDescription": "The study will be an un-blinded, Phase 2, randomized, 1:1, prospective trial comparing patients in septic shock receiving norepinephrine and vasopressin followed by phenylephrine versus ProvayBlue\u00ae as the third-line vasopressor. The third line vasopressor will be compared at 1 hour to see if it affects the patient's mean arterial blood pressure (MAP)."
        },
        "conditionsModule": {
            "conditions": [
                "Septic Shock"
            ],
            "keywords": [
                "Methylene Blue",
                "Vasopressors",
                "Septic Shock",
                "Provay Blue\u00ae"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 250,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Control group",
                    "type": "EXPERIMENTAL",
                    "description": "Patients in the control group will have phenylephrine infusion starting at 50 mcg/min and titrated to maintain a MAP \\>65 mmHg as a third line vasopressor. Maximum dose of Phenylephrine is 300 mcg/min.",
                    "interventionNames": [
                        "Drug: Phenylephrine"
                    ]
                },
                {
                    "label": "Intervention group",
                    "type": "EXPERIMENTAL",
                    "description": "Patients enrolled in the intervention group will receive 2 mg/kg IBW (Ideal Body Weight) bolus, given over 15 mins, of ProvayBlue\u00ae followed by a concomitant infusion at 2 mg/kg/hr (IBW) mixed in D5W, which will continue for 24 hours. ProvayBlue\u00ae ( Methylene Blue) will be used as the third-line vasopressor.",
                    "interventionNames": [
                        "Drug: Methylene Blue"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Methylene Blue",
                    "description": "Prior to the initiation of the randomized treatment, the subject will have received 2 vasopressors ( norepinephrine and vasopressin), they will be initiated on IV hydrocortisone . Once the patient is unable to maintain a mean arterial pressure of \\>65mmHg and the hydrocortisone has been administered there will be an addition of a third-line vasopressor.\n\nPatients enrolled in the intervention group will receive ProvayBlue\u00ae and Patients enrolled in the control group will receive Phenylephrine infusion as a third line vasopressor in the treatment of septic shock.",
                    "armGroupLabels": [
                        "Intervention group"
                    ],
                    "otherNames": [
                        "ProvayBlue\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Phenylephrine",
                    "description": "Prior to the initiation of the randomized treatment, the subject will have received 2 vasopressors ( norepinephrine and vasopressin) already , they will be initiated on IV hydrocortisone . Once the patient is unable to maintain a mean arterial pressure of \\>65mmHg and the hydrocortisone has been administered there will be an addition of a third-line vasopressor.\n\nPatients enrolled in the intervention group will receive ProvayBlue\u00ae and Patients enrolled in the control group will receive Phenylephrine infusion as a third line vasopressor in the treatment of septic shock.",
                    "armGroupLabels": [
                        "Control group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in mean arterial pressure",
                    "description": "The primary objective is to determine if the administration of ProvayBlue\u00ae is non-inferior to the use of phenylephrine as a third-line vasopressor to keep a mean arterial pressure (MAP)\\>65 mmhg after one hour and at 24 hours after the initiation of the drugs.",
                    "timeFrame": "One hour and 24 hours after dose"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence of acute kidney injury requiring dialysis",
                    "description": "The secondary objectives are to see if the total vasopressor dosing and renal replacement needs are different in those patients receiving ProvayBlue\u00ae rather than standard care with escalating number of vasopressors.",
                    "timeFrame": "through time of patient discharge, an average of 8 days after admission"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Meets Sepsis-3 Criteria (Suspected source of infection plus any 2 criteria of the qSOFA)\n\n2 .Septic Shock (any patient requiring vasopressor therapy to maintain MAP \\>65 mmHg or any patient with serum lactate \\>2 mmol/dL even in the absence of hypovolemia ).\n\n3) Greater than 18 years old\n\n4 ) ICU Admission\n\nExclusion Criteria:\n\nInability to obtain informed consent from an appropriate surrogate decision maker.\n\nAlso:\n\n1. Children less than 18 years old\n2. Pregnant women or positive urinary pregnancy test in reproductive-aged women\n3. Prisoners\n4. Evolving myocardial infarction or known cardiomyopathy with documented EF\\<35%\n5. Known grade 3 diastolic dysfunction document by echocardiogram\n6. Known hypersensitivity to thiazine dyes\n7. Pulmonary hypertension that is currently requiring vasodilator therapy\n8. Concurrent form of shock present or suspected: Obstructive, Neurogenic, Hemorrhagic\n9. Known documented history of G6PD deficiency or favism\n10. Active prior to admission medication prescription for a SSRI or SNRI , systemic heparin anticoagulation or other medications listed above (under Study Agent). These medications will be listed in the printed enrollment form.\n11. Severe renal failure is a contraindication to use of ProvayBlue\u00ae.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Frank Biscardi, MD",
                    "role": "CONTACT",
                    "phone": "540-981-7000",
                    "email": "fhbiscardi@carilionclinic.org"
                },
                {
                    "name": "Ruth Ndolo, RN",
                    "role": "CONTACT",
                    "phone": "540-266-6557",
                    "email": "rmndolo@carilionclinic.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Frank Biscardi",
                    "affiliation": "Carilion Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Carilion Clinic",
                    "status": "RECRUITING",
                    "city": "Roanoke",
                    "state": "Virginia",
                    "zip": "24014",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Frank Biscardi",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.27097,
                        "lon": -79.94143
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "To publish aggregated data"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012772",
                    "term": "Shock, Septic"
                },
                {
                    "id": "D000012769",
                    "term": "Shock"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000018805",
                    "term": "Sepsis"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000018746",
                    "term": "Systemic Inflammatory Response Syndrome"
                },
                {
                    "id": "D000007249",
                    "term": "Inflammation"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M15577",
                    "name": "Shock",
                    "asFound": "Shock",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15580",
                    "name": "Shock, Septic",
                    "asFound": "Septic Shock",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20864",
                    "name": "Sepsis",
                    "relevance": "LOW"
                },
                {
                    "id": "M16869",
                    "name": "Toxemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M20818",
                    "name": "Systemic Inflammatory Response Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M10293",
                    "name": "Inflammation",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010656",
                    "term": "Phenylephrine"
                },
                {
                    "id": "D000010109",
                    "term": "Oxymetazoline"
                },
                {
                    "id": "D000008751",
                    "term": "Methylene Blue"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002316",
                    "term": "Cardiotonic Agents"
                },
                {
                    "id": "D000009184",
                    "term": "Mydriatics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000013566",
                    "term": "Sympathomimetics"
                },
                {
                    "id": "D000014662",
                    "term": "Vasoconstrictor Agents"
                },
                {
                    "id": "D000014663",
                    "term": "Nasal Decongestants"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                },
                {
                    "id": "D000058646",
                    "term": "Adrenergic alpha-1 Receptor Agonists"
                },
                {
                    "id": "D000000316",
                    "term": "Adrenergic alpha-Agonists"
                },
                {
                    "id": "D000000322",
                    "term": "Adrenergic Agonists"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12575",
                    "name": "Norepinephrine",
                    "relevance": "LOW"
                },
                {
                    "id": "M11726",
                    "name": "Methylene Blue",
                    "asFound": "Respiratory Distress Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9912",
                    "name": "Hydrocortisone",
                    "relevance": "LOW"
                },
                {
                    "id": "M13561",
                    "name": "Phenylephrine",
                    "asFound": "Achieved",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13031",
                    "name": "Oxymetazoline",
                    "asFound": "Achieved",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17409",
                    "name": "Vasoconstrictor Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M17414",
                    "name": "Vasopressins",
                    "relevance": "LOW"
                },
                {
                    "id": "M4437",
                    "name": "Arginine Vasopressin",
                    "relevance": "LOW"
                },
                {
                    "id": "M155245",
                    "name": "Hydrocortisone 17-butyrate 21-propionate",
                    "relevance": "LOW"
                },
                {
                    "id": "M228609",
                    "name": "Hydrocortisone acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M263259",
                    "name": "Hydrocortisone hemisuccinate",
                    "relevance": "LOW"
                },
                {
                    "id": "M4854",
                    "name": "Benzocaine",
                    "relevance": "LOW"
                },
                {
                    "id": "M5572",
                    "name": "Cardiotonic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M12139",
                    "name": "Mydriatics",
                    "relevance": "LOW"
                },
                {
                    "id": "M16345",
                    "name": "Sympathomimetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M7966",
                    "name": "Ephedrine",
                    "relevance": "LOW"
                },
                {
                    "id": "M27586",
                    "name": "Pseudoephedrine",
                    "relevance": "LOW"
                },
                {
                    "id": "M17410",
                    "name": "Nasal Decongestants",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M3668",
                    "name": "Adrenergic alpha-Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M3673",
                    "name": "Adrenergic Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "T433",
                    "name": "Tannic Acid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "CaAg",
                    "name": "Cardiotonic Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "NaAg",
                    "name": "Natriuretic Agents"
                },
                {
                    "abbrev": "Coag",
                    "name": "Coagulants"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "CNSSti",
                    "name": "Central Nervous System Stimulants"
                },
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                }
            ]
        }
    },
    "hasResults": false
}